Abstract

PDZK1 is a four PDZ domain-containing scaffold protein that binds to scavenger receptor class B, type I (SR-BI), the high density lipoprotein receptor, by its first PDZ domain (PDZ1). PDZK1 knock-out mice exhibit a >95% decrease in hepatic SR-BI protein and consequently an approximately 70% increase in plasma cholesterol in abnormally large high density lipoprotein particles. These defects are corrected by hepatic overexpression of full-length PDZK1 but not the PDZ1 domain alone, which partially restores SR-BI protein abundance but not cell surface expression or function. We have generated PDZK1 knock-out mice with hepatic expression of four PDZK1 transgenes encoding proteins with nested C-terminal truncations: pTEM, which lacks the three C-terminal residues (putative PDZ-binding motif), and PDZ1.2, PDZ1.2.3, or PDZ1.2.3.4, which contain only the first two, three, or four N-terminal PDZ domains, respectively, but not the remaining C-terminal sequences. Hepatic overexpression of pTEM restored normal hepatic SR-BI abundance, localization, and function. Hepatic overexpression of PDZ1.2 or PDZ1.2.3 partially restored SR-BI abundance ( approximately 12 or approximately 30% of wild type, respectively) but did not (PDZ1.2) or only slightly (PDZ1.2.3) restored hepatic SR-BI cell surface localization and function. Hepatic overexpression of PDZ1.2.3.4 completely restored SR-BI protein abundance, cell surface expression, and function (normalization of plasma cholesterol levels). Thus, all four PDZ domains in PDZK1, but not PDZ1-3 alone, are sufficient for its normal control of the abundance, localization, and therefore function of hepatic SR-BI, whereas the residues C-terminal to the PDZ4 domain, including the C-terminal putative PDZ-binding domain, are not required.

Highlights

  • SR-BI3 plays a significant role in lipoprotein metabolism as the high density lipoprotein (HDL) receptor [1]

  • Effects of PDZ1.2-Tg, PDZ1.2.3-Tg, and PDZ1.2.3.4-Tg on Lipoprotein Metabolism and Hepatic SR-BI Expression—In WT mice, we found that hepatic expression of PDZ1.2-Tg (1.3and 5.5-fold higher than that of endogenous PDZK1 in WT), PDZ1.2.3 (0.2- and 7.9-fold), and PDZ1.2.3.4-Tg (2.8- and 10.6fold) did not lead to statistically significant changes in plasma cholesterol levels (Figs. 4B, 5B, and 6B, left panels) or in the size distributions of lipoproteins (FPLC lipoprotein cholesterol profiles; Figs. 4C, 5C, and 6C, white and gray circles)

  • Overexpression in hepatocytes of PDZK1 KO mice of a transgene encoding the full-length PDZK1 completely restores the abundance, surface localization, and function of SR-BI to that seen in WT mice [30]

Read more

Summary

EXPERIMENTAL PROCEDURES

Generation of PDZ1.2, PDZ1.2.3, PDZ1.2.3.4, and pTEM Transgenic Mice—PDZ1.2, PDZ1.2.3, PDZ1.2.3.4, and pTEM transgenic mice were generated using the pLIV-LE6 plasmid, kindly provided by Dr John M. The sequences of the recombinant plasmids were confirmed by DNA sequencing These constructs were linearized by SacII/ SpeI digestion, and the resulting 5.7-kb (PDZ1.2-Tg), 6.1-kb (PDZ1.2.3-Tg), 6.4-kb (PDZ1.2.3.4-Tg), and 6.6-kb (pTEM-Tg) constructs were used to generate transgenic mice using standard procedures [35]. Founder animals for these transgenes in an FVB/N genetic background were identified by PCR performed on tail DNA using the following oligonucleotide primers: for the PDZ1.2-Tg and PDZ1.2.3-Tg, one primer corresponding to the PDZK1 cDNA sequence (CAATGGTGTCTTTGTCGACAAG) and one corresponding to the 3Ј-end of the human apoE gene sequence included in the cloning vector Mean values for experimental groups are considered statistically significantly different for p Ͻ 0.05 for both types of tests

RESULTS
When we examined hepatic
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.